Skip to content

Understanding Daily Changes in BDD Risk Using Smartphones

Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04254575
Enrollment
87
Registered
2020-02-05
Start date
2020-07-15
Completion date
2023-04-28
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Dysmorphic Disorders

Brief summary

Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.

Interventions

OTHERNone, observational study only (no interventions)

None, observational study only (no interventions)

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age \>=18 * Current primary diagnosis of BDD * BDD severity \>= moderate * Living in US * English proficiency * Owns an Android or iOS (Apple) smartphone * Has regular Wifi-enabled internet access for data downloads

Design outcomes

Primary

MeasureTime frameDescription
Self-reported anxiety intensity, rated from 1 (very slightly or not at all) to 5 (extremely)3 monthsEcological momentary assessment (EMA) of anxiety intensity, where higher scores indicated more severe anxiety.
Self-reported shame intensity, based on Positive and negative affect scale (PANAS) shame item, rated from 1 (very slightly or not at all) to 5 (extremely)3 monthsEcological momentary assessment (EMA) of shame intensity, where higher scores indicate more severe shame.
Self-reported negative affect intensity, based on Positive and negative affect scale (PANAS) negative affect items (averaged), rated from 1 (very slightly or not at all) to 5 (extremely)3 monthsEcological momentary assessment (EMA)-rated general negative affect intensity, where higher scores indicate more severe negative affect.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026